Header cover image

Pakistani (KSE) Healthcare Sector Analysis

UpdatedMay 17, 2024
DataAggregated Company Financials
Companies13
  • 7D1.6%
  • 3M41.0%
  • 1Y59.6%
  • YTD28.1%

In the last week, the Healthcare industry is up 6.0%, with Abbott Laboratories (Pakistan) up 5.3%. Meanwhile, AGP actually underperformed within the industry, shrinking 5.1% in the last week. In the last 12 months, the industry was up 58%. Earnings are forecast to grow by 38% annually.

Sector Valuation and Performance

Has the Pakistani Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 17 May 2024PK₨242.4bPK₨263.5bPK₨10.4b15x23.2x0.9x
Sun, 14 Apr 2024PK₨206.8bPK₨257.0bPK₨8.2b19.6x25.1x0.8x
Tue, 12 Mar 2024PK₨186.3bPK₨251.1bPK₨8.0b12.9x23.2x0.7x
Thu, 08 Feb 2024PK₨182.7bPK₨248.2bPK₨7.9b12.8x23.2x0.7x
Sat, 06 Jan 2024PK₨187.5bPK₨248.2bPK₨7.9b13.9x23.8x0.8x
Mon, 04 Dec 2023PK₨191.2bPK₨245.1bPK₨7.8b14.5x24.6x0.8x
Wed, 01 Nov 2023PK₨155.5bPK₨237.4bPK₨8.2b12.3x19x0.7x
Fri, 29 Sep 2023PK₨138.3bPK₨234.0bPK₨9.9b10.8x13.9x0.6x
Sun, 27 Aug 2023PK₨147.4bPK₨230.3bPK₨10.4b11x14.1x0.6x
Tue, 25 Jul 2023PK₨156.6bPK₨230.3bPK₨10.4b12.4x15x0.7x
Thu, 22 Jun 2023PK₨138.9bPK₨230.3bPK₨10.4b10.9x13.3x0.6x
Sat, 20 May 2023PK₨155.4bPK₨218.4bPK₨14.3b11x10.8x0.7x
Mon, 17 Apr 2023PK₨152.7bPK₨217.4bPK₨15.2b9.3x10x0.7x
Wed, 15 Mar 2023PK₨159.2bPK₨214.7bPK₨16.5b9.2x9.6x0.7x
Fri, 10 Feb 2023PK₨171.7bPK₨211.8bPK₨16.8b9.5x10.2x0.8x
Sun, 08 Jan 2023PK₨173.4bPK₨211.8bPK₨16.8b9.9x10.3x0.8x
Tue, 06 Dec 2022PK₨195.1bPK₨210.0bPK₨16.6b10.8x11.7x0.9x
Thu, 03 Nov 2022PK₨210.0bPK₨206.3bPK₨18.2b11.1x11.5x1x
Sat, 01 Oct 2022PK₨217.0bPK₨200.0bPK₨20.2b10.5x10.7x1.1x
Mon, 29 Aug 2022PK₨233.5bPK₨189.9bPK₨23.3b9.8x10x1.2x
Wed, 27 Jul 2022PK₨227.2bPK₨189.9bPK₨23.3b9.6x9.8x1.2x
Fri, 24 Jun 2022PK₨233.5bPK₨188.5bPK₨23.1b9.6x10.1x1.2x
Sun, 22 May 2022PK₨230.3bPK₨184.3bPK₨22.9b9.5x10x1.2x
Tue, 19 Apr 2022PK₨258.6bPK₨183.4bPK₨23.0b11x11.3x1.4x
Thu, 17 Mar 2022PK₨250.8bPK₨181.2bPK₨21.4b11x11.7x1.4x
Sat, 12 Feb 2022PK₨265.7bPK₨180.0bPK₨21.5b12.2x12.4x1.5x
Mon, 10 Jan 2022PK₨270.5bPK₨180.0bPK₨21.5b12.2x12.6x1.5x
Wed, 08 Dec 2021PK₨257.6bPK₨179.9bPK₨21.5b11.8x12x1.4x
Fri, 05 Nov 2021PK₨293.7bPK₨179.9bPK₨21.5b14.1x13.7x1.6x
Sun, 03 Oct 2021PK₨290.4bPK₨172.1bPK₨19.9b16.1x14.6x1.7x
Tue, 31 Aug 2021PK₨309.3bPK₨170.6bPK₨19.1b17.9x16.2x1.8x
Wed, 07 Jul 2021PK₨305.0bPK₨165.4bPK₨18.9b16.8x16.2x1.8x
Price to Earnings Ratio

16.8x


Total Market Cap: PK₨291.0bTotal Earnings: PK₨17.3bTotal Revenue: PK₨157.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Healthcare Sector Price to Earnings3Y Average 14.5x202220232024
Current Industry PE
  • Investors are optimistic on the Pakistani Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 23.7x which is higher than its 3-year average PE of 14.5x.
  • The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.94x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 16% per year over the last three years.
  • Meanwhile revenues for these companies have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare sector?

PK Market2.61%
Healthcare1.62%
Healthcare Services3.69%
Pharma1.60%
Medical Equipment0%
Healthtech0%
Biotech0%
Life Sciences-1.56%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 52.3x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 14.6x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 38% over the next 5 years.
  • This is better than its past earnings decline of 2.1% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 38% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABOT Abbott Laboratories (Pakistan)PK₨668.495.3%
+PK₨3.3b
71.4%PE32.7x
HINOON Highnoon LaboratoriesPK₨670.342.6%
+PK₨883.2m
85.2%PE14.5x
GLAXO GlaxoSmithKline PakistanPK₨135.852.0%
+PK₨850.3m
61.7%PE81x
HPL Hoechst PakistanPK₨1.43k6.2%
+PK₨810.6m
106.3%PE13.1x
SHFA Shifa International HospitalsPK₨140.006.1%
+PK₨505.7m
15.7%PE8.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HPL

PK₨1,434.05

Hoechst Pakistan

7D

6.2%

1Y

106.3%

HINOON

PK₨670.34

Highnoon Laboratories

7D

2.6%

1Y

85.2%

AGP

PK₨89.49

AGP

7D

-5.1%

1Y

72.6%

SEARL

PK₨58.73

Searle

7D

-2.8%

1Y

17.1%

CPHL

PK₨31.62

Citi Pharma

7D

-4.1%

1Y

34.2%

GGGL

PK₨7.04

Ghani Global Glass

7D

4.3%

1Y

11.9%

GLAXO

PK₨135.85

GlaxoSmithKline Pakistan

7D

2.0%

1Y

61.7%

ABOT

PK₨668.49

Abbott Laboratories (Pakistan)

7D

5.3%

1Y

71.4%

SHFA

PK₨140.00

Shifa International Hospitals

7D

6.1%

1Y

15.7%

IBLHL

PK₨34.60

IBL HealthCare

7D

-2.7%

1Y

26.2%

OTSU

PK₨128.12

Otsuka Pakistan

7D

-4.9%

1Y

75.5%

MACTER

PK₨89.85

Macter International

7D

-3.9%

1Y

6.2%

FEROZ

PK₨252.34

Ferozsons Laboratories

7D

0.7%

1Y

85.5%